enkephalin, pen(2,5)-4-chloro-phe(4)- has been researched along with diprenorphine in 1 studies
Studies (enkephalin, pen(2,5)-4-chloro-phe(4)-) | Trials (enkephalin, pen(2,5)-4-chloro-phe(4)-) | Recent Studies (post-2010) (enkephalin, pen(2,5)-4-chloro-phe(4)-) | Studies (diprenorphine) | Trials (diprenorphine) | Recent Studies (post-2010) (diprenorphine) |
---|---|---|---|---|---|
12 | 0 | 1 | 538 | 7 | 27 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kübler, W; Mura, RA; Niroomand, F; Piacentini, L | 1 |
1 other study(ies) available for enkephalin, pen(2,5)-4-chloro-phe(4)- and diprenorphine
Article | Year |
---|---|
Opioid receptor agonists activate pertussis toxin-sensitive G proteins and inhibit adenylyl cyclase in canine cardiac sarcolemma.
Topics: Adenylate Cyclase Toxin; Adenylyl Cyclases; Analgesics; Analysis of Variance; Animals; Diprenorphine; Dogs; Dose-Response Relationship, Drug; Dynorphins; Endorphins; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; GTP Phosphohydrolases; GTP-Binding Proteins; Myocardium; Naltrexone; Narcotic Antagonists; Pertussis Toxin; Sarcolemma; Virulence Factors, Bordetella | 1996 |